Document is current
Any future updates will be listed below
-
Authors
Phung, Abraham T.
Shah, Jaimin R.
Dong, Tao
Reid, Tony
Larson, Christopher
Sanchez, Ana B.
Oronsky, Bryan
Trogler, William C.
Kummel, Andrew C.
Aisagbonhi, Omonigho
Blair, Sarah L.
-
Funding
Funding for this research was provided by:
EpicentRx
Kreuger V Wyeth
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 9 August 2024
First Online: 10 September 2024
Declarations
:
: All tissues were collected by the Moores Cancer Center Biorepository from consented patients under a University of California, San Diego Human Research Protections Program Institutional Review Board approved protocol (HRPP# 181755). Biorepository subjects provide a written consent which is maintained in the Biorepository archives.
: Not applicable.
: This study was funded by EpicentRx Inc. Tony Reid is the Chief Executive Officer and Chief Scientific Officer at EpicentRx Inc. Christopher Larson is the Vice President of viral therapy, Bryan Oronsky is the Chief Development Officer, and Ana B. Sanchez is a Senior Project Scientist at EpicentRx Inc. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
